calendar
15,271 catalysts · 15,271 approval
Week of Aug 21, 2023
3Aug 25, 2023approvalLISDEXAMFETAMINE DIMESYLATE — FDA approvalLISDEXAMFETAMINE DIMESYLATE
Sponsor: ASCENT PHARMS INC. Form: CAPSULE. Route: ORAL
15,271 catalysts · 15,271 approval
Sponsor: ASCENT PHARMS INC. Form: CAPSULE. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET. Route: ORAL
Sponsor: CELGENE CORP. Form: POWDER. Route: SUBCUTANEOUS
Sponsor: STRIDES PHARMA INTL. Form: FOR SUSPENSION. Route: ORAL
Sponsor: ZYDUS PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: CAPSULE. Route: ORAL
Sponsor: MYLAN. Form: TABLET. Route: ORAL
Sponsor: MYLAN. Form: TABLET. Route: ORAL
Sponsor: MYLAN. Form: TABLET. Route: ORAL
Sponsor: MYLAN. Form: TABLET. Route: ORAL
Sponsor: MYLAN. Form: TABLET. Route: ORAL
Sponsor: MYLAN. Form: TABLET. Route: ORAL
Sponsor: CELLTRION. Form: INJECTABLE. Route: INJECTION
Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: AYRMID PHARMA. Form: POWDER. Route: SUBCUTANEOUS
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL
Sponsor: INDIVIOR. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: COHERUS BIOSCIENCES INC. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: UCB INC. Form: SOLUTION. Route: ORAL
Sponsor: UCB INC. Form: SOLUTION. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL
Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL
Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL
Sponsor: REMPEX. Form: POWDER. Route: INTRAVENOUS
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: CELLTRION. Form: INJECTABLE. Route: INJECTION